DXCM
DEXCOM INCCompany Information
- Company Name
- DEXCOM INC
- CIK
- CIK0001093557
- Category
- Large accelerated filer
- Ticker: Exchange
- DXCM: Nasdaq
- Fiscal Year End
- December 31
- Owner Organization
- 08 Industrial Applications and Services
- SIC
- 3841
- SIC Description
- Surgical & Medical Instruments & Apparatus
- Ticker
- DXCM
SEC filing data through
Insider Sentiment
- Last purchase
- 2025-11-10
- Last sale
- 2026-09-28
- Shares purchased (TTM)
- 18,200
- Shares sold (TTM)
- 156,047
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 377,093,652
- Shares outstanding
- 382,200,000
- Ownership
- 98.66%
Earnings Market Reaction
- Filing date
- 2026-07-30
- Price on filing date
- —
- 1-month reaction
- …
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 1,105 | 1,118 | 918 | 1,836 | 1,159 | 905 | 606 | 621 | 939 | 851 | 566 | 644 | ||||||
| Accounts Receivable Net Current | 1,258 | 1,089 | 1,216 | 1,110 | 1,349 | 1,155 | 1,006 | 1,002 | 945 | 979 | 974 | 786 | ||||||
| Inventory Net | 726 | 694 | 629 | 604 | 571 | 538 | 543 | 586 | 570 | 589 | 560 | 499 | ||||||
| Prepaid Expense And Other Assets Current | 156 | 134 | 189 | 184 | 181 | 159 | 174 | 182 | 212 | 156 | 168 | 174 | ||||||
| Assets Current | 4,087 | 4,332 | 4,033 | 5,220 | 5,030 | 4,554 | 4,301 | 4,263 | 4,848 | 4,621 | 4,426 | 4,698 | ||||||
| Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization | 1,577 | 1,560 | 1,560 | 1,471 | 1,457 | 1,365 | 1,340 | 1,319 | 1,183 | 1,109 | 1,113 | 1,079 | ||||||
| Operating Lease Right Of Use Asset | 88 | 73 | 77 | 54 | 56 | 59 | 63 | 68 | 71 | 68 | 71 | 73 | ||||||
| Goodwill | 24 | 24 | 24 | 24 | 24 | 23 | 23 | 24 | 23 | 23 | 25 | 25 | ||||||
| Intangible Assets Net Excluding Goodwill | 102 | 63 | 71 | 79 | 87 | 95 | 103 | 106 | 115 | 123 | 135 | 145 | ||||||
| Deferred Income Tax Assets Net | 304 | 296 | 296 | 376 | 496 | 487 | 481 | 487 | 476 | 461 | 419 | 501 | ||||||
| Other Assets Noncurrent | 274 | 286 | 279 | 277 | 176 | 169 | 173 | 88 | 83 | 78 | 75 | 74 | ||||||
| Assets | 6,455 | 6,633 | 6,340 | 7,500 | 7,327 | 6,752 | 6,485 | 6,354 | 6,799 | 6,482 | 6,265 | 6,596 | ||||||
Liabilities Current | ||||||||||||||||||
| Accounts Payable And Other Accrued Liabilities Current | 2,192 | 2,074 | 1,944 | 1,932 | 1,944 | 1,691 | 1,585 | 1,593 | 1,570 | 1,447 | 1,346 | 1,373 | ||||||
| Employee Related Liabilities Current | 136 | 122 | 169 | 170 | 129 | 111 | 112 | 106 | 116 | 111 | 171 | 151 | ||||||
| Convertible Notes Payable Current | - | - | 0 | 1,207 | 1,206 | 1,205 | 1,204 | - | - | - | 0 | 124 | ||||||
| Operating Lease Liability Current | 21 | 21 | 22 | 24 | 23 | 23 | 23 | 22 | 22 | 21 | 21 | 21 | ||||||
| Contract With Customer Liability Current | - | - | - | 3 | 6 | 8 | 8 | 14 | 15 | 16 | 18 | 9 | ||||||
| Other Liabilities Current | 9 | 8 | 8 | - | - | - | 8 | - | - | - | - | - | ||||||
| Liabilities Current | 2,358 | 2,224 | 2,143 | 3,336 | 3,309 | 3,037 | 2,932 | 1,735 | 1,722 | 1,594 | 1,556 | 1,679 | ||||||
| Convertible Long Term Notes Payable | 1,243 | 1,242 | 1,241 | 1,240 | 1,239 | 1,238 | 1,237 | 2,440 | 2,438 | 2,436 | 2,434 | 2,432 | ||||||
| Operating Lease Liability Noncurrent | 83 | 69 | 73 | 51 | 55 | 60 | 65 | 71 | 77 | 76 | 80 | 83 | ||||||
| Other Liabilities Noncurrent | 151 | 142 | 137 | 147 | 152 | 150 | 148 | 130 | 128 | 129 | 126 | 134 | ||||||
| Liabilities | 3,834 | 3,676 | 3,594 | 4,774 | 4,754 | 4,485 | 4,382 | 4,375 | 4,365 | 4,235 | 4,196 | 4,328 | ||||||
Stockholders Equity | ||||||||||||||||||
| Preferred Stock Value Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Value Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Additional Paid In Capital Common Stock | 2,377 | 2,338 | 2,282 | 2,247 | 2,188 | 2,142 | 2,094 | 2,051 | 1,992 | 2,511 | 3,515 | 3,618 | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | 90 | 106 | 115 | 82 | 84 | 2 | -8 | 63 | -38 | -37 | -17 | -36 | ||||||
| Retained Earnings Accumulated Deficit | 2,883 | 2,633 | 2,434 | 2,167 | 1,883 | 1,703 | 1,598 | 1,446 | 1,311 | 1,168 | 1,021 | 765 | ||||||
| Treasury Stock Common Value | -2,728 | -2,121 | -2,085 | -1,769 | -1,581 | -1,581 | -1,581 | -1,581 | -832 | -1,395 | -2,451 | -2,080 | ||||||
| Stockholders Equity | 2,621 | 2,957 | 2,746 | 2,726 | 2,573 | 2,267 | 2,103 | 1,979 | 2,434 | 2,247 | 2,069 | 2,268 | ||||||
| Liabilities And Stockholders Equity | 6,455 | 6,633 | 6,340 | 7,500 | 7,327 | 6,752 | 6,485 | 6,354 | 6,799 | 6,482 | 6,265 | 6,596 | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Preferred Stock Shares Authorized | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | ||||||
| Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 800 | 800 | 800 | 800 | 800 | 800 | 800 | 800 | 800 | 800 | 800 | 800 | ||||||
| Common Stock Shares Issued | 412 | 412 | 411 | 411 | 410 | 410 | 409 | 409 | 409 | 409 | 407 | 406 | ||||||
| Shares Outstanding | 377 | 386 | 385 | 390 | 392 | 392 | 391 | 391 | 401 | 396 | 385 | 386 | ||||||
| Treasury Stock Common Shares | 35 | 26 | 26 | 21 | 18 | 18 | 18 | 18 | 8 | 12 | 22 | 19 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialDEXCOM INC (DXCM) — SEC Financial Statements & Analysis
DEXCOM INC (DXCM) is a surgical & medical instruments & apparatus company, incorporated in DE. DEXCOM INC trades on Nasdaq as: DXCM. DEXCOM INC (DXCM)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-07-30. Based on that filing, DEXCOM INC carries a market cap of $25.74B, a P/E ratio of 25.75x, a P/B ratio of 9.82x, a P/S ratio of 5.18x, an enterprise value of $25.88B, and an EV/EBITDA multiple of 18.44x. On profitability, it posts a gross margin of 62.47%, an operating margin of 22.92%, a net margin of 20.12%, a Return on Equity (ROE) of 38.49%, a Return on Assets (ROA) of 14.51%, and a Return on Invested Capital (ROIC) of 26.16%. Per share, it reports EPS of $2.62, diluted EPS of $2.56, free cash flow per share of $3.68, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of 15.54% year-over-year, net income growth of 74.93% year-over-year, and EPS growth of 79.46% year-over-year. On the balance sheet, it maintains a current ratio of 1.73x, a quick ratio of 1.36x, working capital of $1.73B, a debt-to-equity ratio of 1.46x, a debt ratio of 0.59, an interest coverage ratio of 110.44x, free cash flow of $1.41B (TTM), and net debt of $137.60M. Figures sourced from SEC EDGAR.
- Market Cap
- $25.74B
- P/E TTM
- 25.75x
- EPS TTM
- $2.62
- P/B TTM
- 9.82x
- ROE TTM
- 38.49%
- ROA TTM
- 14.51%
- Debt To Equity
- 1.46x
- Free Cash Flow TTM
- $1.41B
- Net Revenue TTM Growth 1Y
- 15.54%
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is DEXCOM INC in?
DEXCOM INC (DXCM) operates in the Surgical & Medical Instruments & Apparatus industry.
What exchange does DXCM trade on?
DEXCOM INC (DXCM) trades on the Nasdaq.
Where is DEXCOM INC incorporated?
DEXCOM INC is incorporated in DE.
When was DEXCOM INC (DXCM)'s most recent SEC filing?
DEXCOM INC (DXCM)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-07-30.
What is DXCM's market cap?
DEXCOM INC (DXCM) has a market capitalization of $25.74B as of 2026-06-30.
What is DXCM's P/E ratio?
DEXCOM INC (DXCM)'s trailing twelve month P/E ratio is 25.75x as of 2026-06-30.
What is DXCM's EPS (earnings per share)?
DEXCOM INC (DXCM)'s trailing twelve month EPS is $2.62 as of 2026-06-30.
What is DXCM's ROE (return on equity)?
DEXCOM INC (DXCM)'s trailing twelve month Return on Equity (ROE) is 38.49% as of 2026-06-30.
What is DXCM's ROA (return on assets)?
DEXCOM INC (DXCM)'s trailing twelve month Return on Assets (ROA) is 14.51% as of 2026-06-30.
What is DXCM's ROIC (return on invested capital)?
DEXCOM INC (DXCM)'s trailing twelve month Return on Invested Capital (ROIC) is 26.16% as of 2026-06-30.
What is DXCM's EV/EBITDA?
DEXCOM INC (DXCM)'s trailing twelve month EV/EBITDA is 18.44x as of 2026-06-30.